Results 91 to 100 of about 12,561 (235)

Mucous Membrane Pemphigoid After Anti‐PD‐1 Therapy: Risk‐Stratified Management and Treatment Outcomes

open access: yesInternational Journal of Dermatology, Volume 65, Issue 7, Page 1376-1382, July 2026.
ABSTRACT Mucous membrane pemphigoid (MMP) following anti‐programmed cell death‐1 (PD‐1) therapy is rare but increasingly reported. Management of high‐ and low‐risk MMP in this setting and the potential oncologic trade‐offs remain poorly defined. We performed a narrative synthesis of all published cases of anti‐PD‐1‐associated MMP, following MEDLINE ...
Serena Dienes   +2 more
wiley   +1 more source

Bullous pemphigoid associated with prostate adenocarcinoma [PDF]

open access: yes, 2004
Bullous pemphigoid is a common autoimmune skin disease characterized by the presence of subepidermal blisters. It has been associated with underlying neoplasia in isolated reports.
6zt\ufcrkcan Serap, Ermertcan Aylin T\ufcrel , Sahin Mustafa Turhan , T\ufcrkdogan Peyker , Inanir Isil, Lekili Murat
core   +2 more sources

Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly

open access: yesPsoriasis: Targets and Therapy, 2023
Vito Di Lernia, Francesca Peccerillo, Elena Ficarelli Dermatology Unit, Azienda Unità Sanitaria Locale- IRCCS di Reggio Emilia, Reggio Emilia, ItalyCorrespondence: Vito Di Lernia, Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di ...
Di Lernia V, Peccerillo F, Ficarelli E
doaj  

Risk of persistent hypogammaglobulinaemia in children with autoimmune bullous dermatoses treated with rituximab

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
S. Benkimoun   +14 more
wiley   +1 more source

Dupilumab Beyond the Airway: Decreased Morbidity in a Real‐World Analysis

open access: yesInternational Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 607-614, June 2026.
ABSTRACT Background Post hoc analyses of clinical trials have characterized dupilumab's adverse effects, yet the real‐world impact in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma is not well described. This study aims to characterize the risks of lymphoma, cardiovascular events, eosinophilia, joint pain, inflammatory arthritis, and ...
Emma J. Anisman   +9 more
wiley   +1 more source

Dupilumab as a treatment for bullous pemphigoid in a liver transplant recipient: A case report

open access: yesSAGE Open Medical Case Reports
Bullous pemphigoid is a common subepidermal autoimmune bullous disease that affects the skin and mucous membranes. It is more prevalent in the elderly, often resulting in significant morbidity and mortality.
Sarah S. Rashid   +2 more
doaj   +1 more source

Improvement of Mixed Inflammatory Environment in Nasal Secretions of Diffuse Type 2 Chronic Rhinosinusitis With Nasal Polyps Under Dupilumab

open access: yesClinical and Translational Allergy, Volume 16, Issue 6, June 2026.
ABSTRACT Background In Western countries, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is predominantly associated with a type 2 inflammatory endotype. While nasal secretion analysis shows promise for disease endotyping, current biomarkers remain limited for accurate stratification, disease monitoring, and prediction of treatment response ...
Fabio S. Ryser   +4 more
wiley   +1 more source

Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients

open access: yesFrontiers in Immunology, 2018
Background: Bullous pemphigoid is a subepidermal blistering skin disease, associated with autoantibodies to hemidesmosomal proteins, complement activation at the dermal-epidermal junction, and dermal granulocyte infiltration.
Roxana M. Chiorean   +9 more
doaj   +1 more source

RASGRP1 Deficiency Manifesting as Severe Vasculopathy and Fatal Autoimmune Hemolytic Anemia

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Background RASGRP1 deficiency is a rare inborn error of immunity characterized by immunodeficiency, autoimmunity, and lymphoproliferation. Results We report a 5‐year‐old male with novel homozygous splice‐donor mutations in RASGRP1(c.1720+1G>A and c.1720+2T>C) who presented with severe vasculopathy (ischemic stroke and thrombosis), secondary ...
Kosar Asna Ashari   +5 more
wiley   +1 more source

Bullous Pemphigoid [PDF]

open access: yesJAMA Dermatology, 2013
Misha, Rosenbach   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy